These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3435698)

  • 1. Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.
    Durrant LG; Garnett MC; Gallego J; Armitage NC; Ballantyne KC; Marksman RA; Hardcastle JD; Baldwin RW
    Br J Cancer; 1987 Dec; 56(6):722-6. PubMed ID: 3435698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugates.
    Pimm MV; Armitage NC; Ballantyne K; Baldwin RW; Perkins AC; Durrant LG; Garnett MC; Hardcastle JD
    Cancer Detect Prev Suppl; 1987; 1():249-62. PubMed ID: 3480055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody targeting of methotrexate (MTX) against MTX-resistant tumour cell lines.
    Affleck K; Embleton MJ
    Br J Cancer; 1992 Jun; 65(6):838-44. PubMed ID: 1616855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of a monoclonal antibody-methotrexate conjugate (791T/36-MTX) in patients with colorectal cancer.
    Ballantyne KC; Perkins AC; Pimm MV; Garnett MC; Clegg JA; Armitage NC; Baldwin RW; Hardcastle JD
    Int J Cancer Suppl; 1988; 2():103-8. PubMed ID: 3162436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies for radioimmunodetection of tumours and for targeting.
    Baldwin RW; Embleton MJ; Pimm MV
    Bull Cancer; 1983; 70(2):132-6. PubMed ID: 6575842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of four daunomycin-monoclonal antibody 791T/36 conjugates with anti-tumour activity.
    Gallego J; Price MR; Baldwin RW
    Int J Cancer; 1984 Jun; 33(6):737-44. PubMed ID: 6376376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.
    Pimm MV; Robins RA; Embleton MJ; Jacobs E; Markham AJ; Charleston A; Baldwin RW
    Br J Cancer; 1990 Apr; 61(4):508-13. PubMed ID: 2331436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates.
    Dillman RO; Johnson DE; Ogden J; Beidler D
    Mol Biother; 1989; 1(5):250-5. PubMed ID: 2515870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
    Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
    Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo cytotoxic activity of anti-human leukemia monoclonal antibodies SN5c and SN6 daunorubicin conjugates.
    Biddle WC; Haruta Y; Seon BK; Henderson ES; Sarcione EJ
    Leuk Res; 1989; 13(8):699-707. PubMed ID: 2529399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and selectivity of monoclonal-antibody-targeted drugs and free methotrexate in fluorescence-labelled mixed tumour-cell monolayer cultures and multicellular spheroids.
    Embleton MJ; Charleston A; Affleck K
    Int J Cancer; 1991 Oct; 49(4):566-72. PubMed ID: 1917158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro.
    Garnett MC; Embleton MJ; Jacobs E; Baldwin RW
    Int J Cancer; 1983 May; 31(5):661-70. PubMed ID: 6852982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved synthesis of a methotrexate-albumin-791T/36 monoclonal antibody conjugate cytotoxic to human osteogenic sarcoma cell lines.
    Garnett MC; Baldwin RW
    Cancer Res; 1986 May; 46(5):2407-12. PubMed ID: 3457627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted anti-tumor agents and their cytotoxicity on gastric cancer cells in vitro.
    Li S; Zhang XY; Chen XT; Fan DM; Tan LS; Pan HZ; Huang LQ
    Chin Med J (Engl); 1990 May; 103(5):376-9. PubMed ID: 2118053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma.
    Takahashi T; Yamaguchi T; Kitamura K; Suzuyama H; Honda M; Yokota T; Kotanagi H; Takahashi M; Hashimoto Y
    Cancer; 1988 Mar; 61(5):881-8. PubMed ID: 2962733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity and drug susceptibility of human osteogenic sarcoma cells "escaping" a cytotoxic methotrexate-albumin-monoclonal antibody conjugate.
    Embleton MJ; Garnett MC; Jacobs E; Baldwin RW
    Br J Cancer; 1984 May; 49(5):559-65. PubMed ID: 6586198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugates of monoclonal antibody 791T/36 with methotrexate in cancer therapy.
    Baldwin RW; Embleton MJ; Garnett MC; Pimm MV
    NCI Monogr; 1987; (3):95-9. PubMed ID: 3469528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsuitability of monoclonal antibodies to oncogene proteins for anti-tumour drug-targeting.
    Embleton MJ; Habib NA; Garnett MC; Wood C
    Int J Cancer; 1986 Dec; 38(6):821-7. PubMed ID: 3539823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.